AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Medpace Holdings Surges to 416th in Trading Volume with $214 Million Turnover Despite Stock Price Decline
Generated by AI AgentAinvest Market Brief
Tuesday, May 6, 2025 8:00 pm ET1min read
On May 6, 2025,
(MEDP) experienced a significant increase in trading volume, with a turnover of $214 million, marking a 138.43% rise from the previous day. This surge placed at the 416th position in terms of trading volume for the day. However, the stock price declined by 3.90%, marking the second consecutive day of decline, with a total decrease of 5.36% over the past two days.Medpace Holdings is a global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company is known for its scientifically-driven approach and has been compounding at a 30% CAGR since its IPO in 2017. Medpace offers outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries, making it a key player in the healthcare sector.
Recently, Argus raised its target price for Medpace to $322.00, reflecting a positive outlook on the company's future performance. The average price target for
is $343.22, which is 14.22% higher than the current price. The consensus rating for the stock is "Hold," indicating a balanced view among analysts. Medpace's share price is currently at $289.535, with a GF Value of $355.31, suggesting potential upside based on the relationship between the current stock price and the GF Value.
Ainvest Market Brief
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Morning Market Pulse: Trump’s Federal Pay Raise & Japan’s Policy Shift Drive Pre-Market Moves
Dec.19 2025
What to Trade Today: Volatility and Inflows Drive Pre-Market Moves
Dec.19 2025
U.S. Corporate Actions | Ticker Changes and Dividend Announcements Highlight Activity
Dec.19 2025
Morning Market Pulse: Trump’s Marijuana Rescheduling and AI Policy Shifts
Dec.18 2025
What to Trade Today: Mixed Macro Signals and Short-Term Glimmers in the Diagonal
Dec.18 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet